Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine
Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage
The single-dose solution contains no bacteriostat, antimicrobial agent or added buffer (except for pH adjustment) and is intended for use only as a single-dose injection
Store at 20° to 25°C (68° to 77°F)
Protect from light by retaining in the carton until ready for use
Single-dose glass fliptop vial
10 vials per carton
| Units of Measurement | |
|---|---|
| Manufacturer | SOMERSET PHARMA |
| UNSPSC | 51142315 |
| Product Specification Sheet | |
| SDS | SDS_9SMRST_NALOXONE_HCL_SDV_04MG_ML_1ML_10CT.pdf |
Related Products
Related products
-
Rx-Nervous System
SODIUM CHLORIDE, VL PF 0.9% 10ML (25/PK)
This product has multiple variants. The options may be chosen on the product page
